J M Aubry

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala
    J M Aubry
    Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA 92037, USA
    Neurosci Lett 266:197-200. 1999
  2. ncbi Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases
    J M Aubry
    Departement de Psychiatrie, Clinique de Psychiatrie adulte 2, Chene Bourg, Geneva, Switzerland
    J Clin Psychiatry 61:649-55. 2000
  3. ncbi Phenomenology of mixed states: a principal component analysis study
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland
    Bipolar Disord 9:907-12. 2007
  4. ncbi Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice
    G Bondolfi
    Geneva University Hospitals, Department of Psychiatry, Division of Adult Psychiatry, Geneva, Switzerland
    J Affect Disord 121:268-72. 2010
  5. ncbi A theoretical reappraisal of mixed states: dysphoria as a third dimension
    A Dayer
    Department of Psychiatry, Clinic of Adult Psychiatry II, Geneva, Switzerland
    Bipolar Disord 2:316-24. 2000
  6. ncbi Self-rated residual symptoms do not predict 1-year recurrence of depression
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 2, chemin du Petit Bel Air, 1225 Chene Bourg, Geneva, Switzerland
    Eur Psychiatry 25:52-7. 2010
  7. ncbi Frequency of dysphoria and mixed states
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland
    Psychopathology 41:187-93. 2008
  8. ncbi Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
    G W Smith
    Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037, USA
    Neuron 20:1093-102. 1998

Collaborators

Detail Information

Publications8

  1. ncbi Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala
    J M Aubry
    Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA 92037, USA
    Neurosci Lett 266:197-200. 1999
    ..These results suggest that the tricyclic antidepressant amitriptyline may exert part of its effects through modulation of hypothalamic CRF and of CRF-R1 gene expression in the amygdala...
  2. ncbi Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases
    J M Aubry
    Departement de Psychiatrie, Clinique de Psychiatrie adulte 2, Chene Bourg, Geneva, Switzerland
    J Clin Psychiatry 61:649-55. 2000
    ..Risperidone and olanzapine are atypical antipsychotics that are now widely used in clinical practice...
  3. ncbi Phenomenology of mixed states: a principal component analysis study
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland
    Bipolar Disord 9:907-12. 2007
    ..To contribute to the definition of external and internal limits of mixed states and study the place of dysphoric symptoms in the psychopathology of mixed states...
  4. ncbi Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice
    G Bondolfi
    Geneva University Hospitals, Department of Psychiatry, Division of Adult Psychiatry, Geneva, Switzerland
    J Affect Disord 121:268-72. 2010
    ....
  5. ncbi A theoretical reappraisal of mixed states: dysphoria as a third dimension
    A Dayer
    Department of Psychiatry, Clinic of Adult Psychiatry II, Geneva, Switzerland
    Bipolar Disord 2:316-24. 2000
    ..These subtypes of mixed states will need validation through prospective clinical studies. Biological differences, differential outcome over time, and differential response to treatment will be important validation criteria...
  6. ncbi Self-rated residual symptoms do not predict 1-year recurrence of depression
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, 2, chemin du Petit Bel Air, 1225 Chene Bourg, Geneva, Switzerland
    Eur Psychiatry 25:52-7. 2010
    ..In the absence of a specific instrument for the assessment of residual symptoms, a new 25-item Depression Residual Symptom Scale (DRSS) was elaborated and tested for recurrence prediction over a 1-year follow-up...
  7. ncbi Frequency of dysphoria and mixed states
    G Bertschy
    Division of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland
    Psychopathology 41:187-93. 2008
    ....
  8. ncbi Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
    G W Smith
    Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, California 92037, USA
    Neuron 20:1093-102. 1998
    ..These results suggest that CRFR1 plays an important role both in the development of a functional HPA axis and in mediating behavioral changes associated with anxiety...